Atorvastatin FX1 Impurity is a structurally modified analog of atorvastatin featuring an epoxide bridge and a fused pyrrolooxazin heterocycle, with a hydroxyl group at the 7-position of the pyrrole ring. This impurity arises from oxidative rearrangement of the parent drug's lactone core, incorporating a sodium counterion from carboxylic acid deprotonation. The epoxy functionality and pyrrolooxazin moiety confer distinct spectroscopic and chromatographic properties. It serves as an HPLC reference standard for quantifying synthetic byproducts in atorvastatin drug substance analysis.
On RequestCC(C)C1(C2(C(O2)(C3(N1CCC(O3)CC(CC(=O)[O-])O)C4=CC=C(C=C4)F)C5=CC=CC=C5)C(=O)NC6=CC=CC=C6)O.[Na+]
InChI=1S/C33H35FN2O7.Na/c1-21(2)32(41)31(29(40)35-25-11-7-4-8-12-25)30(43-31,22-9-5-3-6-10-22)33(23-13-15-24(34)16-14-23)36(32)18-17-27(42-33)19-26(37)20-28(38)39;/h3-16,21,26-27,37,41H,17-20H2,1-2H3,(H,35,40)(H,38,39);/q;+1/p-1
SJDGRTRCGRODGR-UHFFFAOYSA-M